Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-053273
Filing Date
2025-06-11
Accepted
2025-06-11 07:53:42
Documents
114
Period of Report
2025-04-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0244900-10q_rafael.htm   iXBRL 10-Q 1934992
2 CERTIFICATION ea024490001ex31-1_rafael.htm EX-31.1 13323
3 CERTIFICATION ea024490001ex31-2_rafael.htm EX-31.2 13324
4 CERTIFICATION ea024490001ex32-1_rafael.htm EX-32.1 5988
5 CERTIFICATION ea024490001ex32-2_rafael.htm EX-32.2 6205
  Complete submission text file 0001213900-25-053273.txt   12198788

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE rfl-20250430.xsd EX-101.SCH 131278
7 XBRL CALCULATION FILE rfl-20250430_cal.xml EX-101.CAL 106290
8 XBRL DEFINITION FILE rfl-20250430_def.xml EX-101.DEF 609295
9 XBRL LABEL FILE rfl-20250430_lab.xml EX-101.LAB 1109886
10 XBRL PRESENTATION FILE rfl-20250430_pre.xml EX-101.PRE 640144
116 EXTRACTED XBRL INSTANCE DOCUMENT ea0244900-10q_rafael_htm.xml XML 1506134
Mailing Address 520 BROAD STREET NEWARK NJ 07120
Business Address 520 BROAD STREET NEWARK NJ 07120 212-658-1450
Rafael Holdings, Inc. (Filer) CIK: 0001713863 (see all company filings)

EIN.: 822296593 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 001-38411 | Film No.: 251038801
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)